Disc Medicine
IRON · NASDAQ
$79.48+$0.55 (+0.70%)TodayMarket closed ·
Prev close $78.93
EPS: actual vs estimate
Beat the estimate in 6 of the last 8 quarters, by 11.4% on average
Next report: , before the market opens
- Quarter
- Q3 FY26
- EPS estimate
- -$1.70
- Revenue estimate
- $250.00K
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$1.78 | -$1.54 | +13.6% |
| Q1 FY26 | -$1.75 | -$1.65 | +5.6% |
| Q4 FY25 | -$1.78 | -$1.64 | +7.8% |
| Q3 FY25 | -$1.49 | -$1.77 | −18.6% |
| Q2 FY25 | -$1.18 | -$1.58 | −33.6% |
| Q1 FY25 | -$1.16 | -$1.02 | +11.7% |
| Q4 FY24 | -$1.12 | -$0.98 | +12.8% |
| Q3 FY24 | -$1.07 | -$0.89 | +17.1% |
Earnings calls
- Special Call - Disc Medicine, Inc.
- Morgan Stanley 24th Annual Global Healthcare Conference
- Special Call - Disc Medicine, Inc.
- Special Call - Disc Medicine, Inc.
- 44th Annual J.P. Morgan Healthcare Conference
- Special Call - Disc Medicine, Inc.
- Jefferies London Healthcare Conference 2025
- Stifel 2025 Healthcare Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.